The CVSS‑9.3 vulnerability allows unauthenticated remote code execution on exposed Marimo servers and was exploited in the wild shortly after disclosure, Sysdig says.

Python-derived pTOS shows promise as a side-effect-free appetite suppressant, offering a new path for weight loss and metabolic therapies.

The MarketWatch News Department was not involved in the creation of this content. Data industry veteran joins to scale enterprise go-to-market as AI Data Automation drives growing demand DENVER and ...

Data industry veteran joins to scale enterprise go-to-market as AI Data Automation drives growing demand DENVER and MANCHESTER, England, March 16, 2026 /PRNewswire/ -- Matillion, builders of the AI ...

Precisely, a global leader in data integrity, is forming a new OEM partnership with Matillion, the intelligent data integration platform, bringing cloud-native Extract Transform Load (ETL) ...

GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission and Cigna's Evernorth unit have officially reached a settlement that resolves allegations that the company's pharmacy benefit manager artificially drove up prices for ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...